Tarsus Pharmaceuticals, Inc.
TARS· Nasdaq
Released Aug 10, 2023, after the close
10-Q filed Aug 10, 2023, 41 days after period end · 0001819790-23-000071
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $15.28M | $22.02M | $0.00 |
| Net Income | -$31.42M | -$5.74M | $6.35M | -$3.25M |
| EPS Diluted |
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR
| -$1.17 |
| -$0.24 |
| $0.29 |
| -$1.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.